April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation
Author Affiliations & Notes
  • Gregory I. Liou
    Ophthalmology, Medical College of Georgia, Augusta, Georgia
  • Mamdouh M. El-Shishtawy
    Biochemistry, Mansoura University, Mansoura, Egypt
  • Ahmed S. Ibrahim
    Ophthalmology, Medical College of Georgia, Augusta, Georgia
    Biochemistry, Mansoura University, Mansoura, Egypt
  • Footnotes
    Commercial Relationships  Gregory I. Liou, None; Mamdouh M. El-Shishtawy, None; Ahmed S. Ibrahim, None
  • Footnotes
    Support  VDI; Egyptian Cultural and Educational Bureau
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1002. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gregory I. Liou, Mamdouh M. El-Shishtawy, Ahmed S. Ibrahim; Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1002. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Early diabetic retinopathy is associated with microglial activation and increased levels of inflammatory cytokines. We have previously shown that cannabidiol (CBD), a non-psychoactive cannabinoid, possesses anti-inflammatory property in Streptozotocin (STZ)-induced diabetic model. However, the underlying mechanism still remains unclear. In this study, we investigated the effect of CBD on microglia activation during diabetes. We examined the role of microglia in retinal inflammation and tested the ability of CBD to inhibit microglial activation in the diabetic retina and in isolated cells.

Methods: : Diabetes was induced by STZ in Sprague Dawley rats. After diabetes was established for two weeks, a single intravitreal injection of CBD or vehicle was performed. Forty-eight hours later, retinas were processed for TNF-α and microglia marker (Iba-1) expression by Quantitative Real Time-PCR. Vitreous samples were analyzed for TNF-α release by Enzyme-linked Immunosorbent Assay. To study the signaling pathways associated with inflammation, retinal microglial cells isolated from newborn rats were cultured and analyzed under diabetic conditions. Cells were treated with glycated albumin, a risk factor of diabetes, in the presence or absence of CBD. Thereafter, Reactive oxygene species (ROS) formation, TNF-α release, and MAP kinase activation were determined.

Results: : Dramatic up-regulation of TNF-α and Iba-1 expression with a very suggestive correlative evidence (R=0.876, p<0.001) were observed in 2-weeks diabetic rats. In the CBD-treated diabetic animals, Iba-1 expression and TNF-α expression and release were all significantly reduced compared to the un-treated diabetic controls. This inflammation is associated with early events including ROS formation and the subsequent activation of ERK and P38 MAP kinases. CBD represses TNF-α expression and release and inhibits ERK and P38 activation in the activated microglial cells by its ROS-scavenging ability.

Conclusions: : These data reveal a previously unrecognized role for CBD in attenuating diabetes-induced retinal inflammation by interfering with inflammatory signaling that occurs in activated microglia. Moreover, these data present new thoughts as to how compounds similar to CBD may suppress retinal complications associated with diabetes.

Keywords: microglia • antioxidants • diabetic retinopathy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.